MK-0366, a new derivative of nalidixic acid, was tested against 250 urinary pathogens including Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa. This new agent was more active than any of the other antibiotics tested, which included carbenicillin, ampicillin, cephalexin, tetracycline, trimethoprim, trimethoprim-sulfamethoxazole, and nalidixic acid. Gentamicin-resistant P. aeruginosa were highly sensitive to MK-0366, with a 90% minimal inhibitory concentration of 0.8 ,ug/ml. Serratia strains were the most resistant organisms, with a 90% minimal inhibitory concentration of 3.1 ,ug/ml. These Shimada, Y. Ueda, and T. Yamazi, 20th ICAAC, abstr. no. 75). One of these compounds, 1-ethyl-6-fluoro-1,4 dihydro-4-oxo-7-(1-piperazynyl)-3-quinoline carboxylic acid (MK-0366), has been found to have superior inhibitory activity for Pseudomonas and Serratia species (2). MK-0366 has also been shown to be very active against Neisseria gonorrhoeae (4).
Nalidixic acid analogues synthesized recently, such as pipemidic acid and others, have exhibited significant antimicrobial activities toward bacteria that are beyond the spectrum of nalidixic acid ( Shimada, Y. Ueda, and T. Yamazi, 20th ICAAC, abstr. no. 75). One of these compounds, 1-ethyl-6-fluoro-1,4 dihydro-4-oxo-7-(1-piperazynyl)-3-quinoline carboxylic acid (MK-0366), has been found to have superior inhibitory activity for Pseudomonas and Serratia species (2) . MK-0366 has also been shown to be very active against Neisseria gonorrhoeae (4) .
The purpose of this study was (i) to report the in vitro activity of MK-0366 against 250 clinical urinary isolates, (ii) to compare the activity of MK-0366 with other oral antimicrobial agents in common clinical use, and (iii) to assess the potency of MK-0366 against gentamicin-resistant Pseudomonas aeruginosa. Specifically, the in vitro activity of MK-0366 was compared with the activities of cephalexin, carbenicillin, tetracycline, trimethoprim, trimethoprim-sulfamethoxazole, and nalidixic acid against P. aeruginosa, Escherichia coli, and Serratia marcescens isolates.
Laboratory standards of the eight antibacterial agents tested were kindly supplied by their manufacturers. Each drug was tested over 11 twofold serial dilutions from the highest concentration: ampicillin, cephalexin, and nalidixic acid, 200 ,Lg/ml; tetracycline and trimethoprim, 100 ,ug/ml; MK-0366, 12.5 p,g/ml; and trimethoprim-sulfamethoxazole 100 ,ug/500 ,ug.
We used 100 strains of E. coli, 100 strains of P. aeruginosa, and 50 strains of S. marcescens. ble growth. Each row of drug dilutions included a drug-free well as a viability and inoculation control. After microtiter plates were scored for MICs, 1.5 ,u1 from each well in each plate was transferred to drug-free Mueller-Hinton agar incubated at 37°C for 18 h, and scored as the lowest concentration of drug showing no colonial growth.
The activity of MK-0366 exceeded the activities of all of the antimicrobial agents tested against the 100 clinical isolates of E. coli (Fig.  1A) . Most of the organisms were sensitive to readily attainable levels of nalidixic acid, cephalexin, ampicillin, and tetracycline. The activities of trimethoprim and trimethoprim-sulfamethoxazole were significantly lower. MK-0366 was potent at levels nearly 100-fold lower than were the other antimicrobial agents with 50% MIC (MIC50) values of 0.05 jig/ml and MIC90 values of 0.2 p,g/ml.
P. aeruginosa isolates were uniformly resistant to nalidixic acid, ampicillin, and cephalexin (Fig. 1B) MK-0366 was least effective against S. marcescens strains, with an MIC50 of 0.4 and an MIC90 of 3.1 jig/ml. This, however, was more than 10 times lower than MICs obtained for any of the other antimicrobial agents tested (Fig.   1C) . MIC90 values for ampicillin and cephalexin were greater than the highest concentrations tested (200 ,ug/ml). The MIC90 values for trimethoprim-sulfamethoxazole and trimethoprim were greater than 100 ,ug/ml.
In only one instance was there a difference of more than twofold between MIC and minimal bactericidal concentration values. This was the activity of tetracycline against Pseudomonas strains, in which the MIC50 was 6.3 and the 50% minimal bactericidal concentration was 50 ,ug/ ml. Many of the 90% minimal bactericidal concentration values exceeded the highest concentration of drugs tested. The minimal bactericidal concentration for trimethoprim-sulfamethoxazole exceeded the maximum level tested for all 250 strains. MK- 
